Most importantly, overexpression of RACGAP1 promoted cell proliferation and colony formation ability under enzalutamide treatment, whereas NLS mutant RACGAP1 failed to mitigate the inhibitory effects of enzalutamide on PCa cells (Fig. 4G). This evidence concerns the gene RACGAP1 and posterior cortical atrophy.